These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

806 related items for PubMed ID: 18063490

  • 1. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR.
    Maturitas; 2008 Jan 20; 59(1):2-6. PubMed ID: 18063490
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C, Dane B, Cetin A, Erginbas M.
    Gynecol Endocrinol; 2007 Jul 20; 23(7):398-403. PubMed ID: 17701771
    [Abstract] [Full Text] [Related]

  • 3. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR.
    Am J Obstet Gynecol; 2001 Nov 20; 185(5):1180-5. PubMed ID: 11717654
    [Abstract] [Full Text] [Related]

  • 4. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep 20; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 5. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
    Popp AW, Bodmer C, Senn C, Fuchs G, Kraenzlin ME, Wyss H, Birkhaeuser MH, Lippuner K.
    Maturitas; 2006 Jan 20; 53(2):191-200. PubMed ID: 16368472
    [Abstract] [Full Text] [Related]

  • 6. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW, Gluck OS, Lang E, Rakov V.
    Menopause; 2005 Jan 20; 12(6):741-8. PubMed ID: 16278618
    [Abstract] [Full Text] [Related]

  • 7. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Vacca F, Genazzani AR.
    Maturitas; 2005 Feb 14; 50(2):91-7. PubMed ID: 15653005
    [Abstract] [Full Text] [Related]

  • 8. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M, Härmä K, Komulainen M, Kiviniemi V, Kröger H, Honkanen R, Alhava E, Jurvelin J, Saarikoski S.
    Maturitas; 2010 Aug 14; 66(4):423-30. PubMed ID: 20547017
    [Abstract] [Full Text] [Related]

  • 9. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 14; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 10. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
    Warming L, Ravn P, Christiansen C.
    Maturitas; 2005 Feb 14; 50(2):78-85. PubMed ID: 15653003
    [Abstract] [Full Text] [Related]

  • 11. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S, Caubel P, Garnero P, Felsenberg D.
    Maturitas; 2004 Jul 15; 48(3):197-207. PubMed ID: 15207885
    [Abstract] [Full Text] [Related]

  • 12. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
    Saarto T, Vehmanen L, Elomaa I, Välimäki M, Mäkelä P, Blomqvist C.
    Br J Cancer; 2001 Apr 20; 84(8):1047-51. PubMed ID: 11308252
    [Abstract] [Full Text] [Related]

  • 13. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Apr 20; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 14. [Effects of long-term and low-dose hormone replacement therapy on bone mineral density in postmenopausal women].
    Nie M, Sun ML, Ge QS.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 20; 28(3):421-4. PubMed ID: 16900649
    [Abstract] [Full Text] [Related]

  • 15. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM, Niskanen LK, Salmi JA, Koulu M, Pesonen U, Uusitupa MI, Komulainen MH, Tuppurainen MT, Kröger H, Jurvelin J, Saarikoski S.
    Bone; 2004 Sep 20; 35(3):589-94. PubMed ID: 15336593
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women.
    Di Carlo C, Tommaselli GA, Di Spiezio Sardo A, Sammartino A, Attianese W, Gargano V, Bifulco G, Nappi C.
    Menopause; 2007 Sep 20; 14(3 Pt 1):450-4. PubMed ID: 17242633
    [Abstract] [Full Text] [Related]

  • 17. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 20; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 18. Difference in bone acquisition among hormonally treated postmenopausal women with normal and low bone mass.
    Taechakraichana N, Jaisamrarn U, Panyakhamlerd K, Chaikittisilpa S, Limpaphayom K.
    J Med Assoc Thai; 2001 Oct 20; 84 Suppl 2():S586-92. PubMed ID: 11853286
    [Abstract] [Full Text] [Related]

  • 19. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
    Maddalozzo GF, Widrick JJ, Cardinal BJ, Winters-Stone KM, Hoffman MA, Snow CM.
    Bone; 2007 May 20; 40(5):1244-51. PubMed ID: 17291843
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous estrogen in prevention of early postmenopausal bone loss in Chinese women.
    Sun A, Lin S, Yu W, Qin M, Chen F, Zhang Y, Wei Y, de Lignieres B.
    Chin Med J (Engl); 2002 Dec 20; 115(12):1790-5. PubMed ID: 12622925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.